Clinical Trials Browser

Phase 2 × OTHER × Hormone-Refractory Prostate Cancer × Clear all

NCT00675545 2012-04-02

A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) Patients

Phase 2 Completed

Hormone-Refractory Prostate Cancer